Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-05-23

Clinical Trial Update: Weight Loss With Intensive Lifestyle Modifications Plus Bariatric Surgery Versus Liraglutide 3 mg [NA]

View source ↗

Summary

A completed clinical trial compared weight loss achieved with intensive lifestyle modifications plus bariatric surgery versus liraglutide 3 mg in people with ob…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • liraglutide (Saxenda) 3 mg (liraglutide)

Snippet

Sponsor: Catholic University of the Sacred Heart | Conditions: Obesity | NA | Status: COMPLETED